Teva Pharmaceuticals
TEVA
TEVA
823 hedge funds and large institutions have $29.9B invested in Teva Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 241 increasing their positions, 350 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more funds holding
Funds holding: 818 → 823 (+5)
2% less capital invested
Capital invested by funds: $30.6B → $29.9B (-$628M)
31% less repeat investments, than reductions
Existing positions increased: 241 | Existing positions reduced: 350
Holders
823
Holding in Top 10
58
Calls
$563M
Puts
$541M
Top Buyers
| 1 | +$902M | |
| 2 | +$501M | |
| 3 | +$443M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$311M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$216M |
Top Sellers
| 1 | -$303M | |
| 2 | -$288M | |
| 3 | -$269M | |
| 4 |
PC
PointState Capital
New York
|
-$268M |
| 5 |
SC
Sculptor Capital
New York
|
-$216M |